SEO URLwww.firestrike.ai/deals/seamless-therapeutics-lilly-acquisition-2026
acquisitionAnnounced · Feb 3, 2026biotechnologySource · CredibleArticle · Factual
Lilly acquires Seamless Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$1.12B
Target
Seamless Therapeutics
Acquirer
Lilly
Full Acquisition
Status
Announced
Lilly agreed to acquire Seamless Therapeutics. Reported deal value: $1.12B. Status: Announced. Sector: biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-02-03. Figures and status may change as filings and press coverage update.
Eli Lilly Is Getting Into the Hearing Loss Market in a $1.12 Billion Deal With Seamless Therapeutics
Deal timeline
Announced
Feb 3, 2026 · nasdaq.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biotechnology with a reported deal value of $1.12B. Figures and status may change as sources update.
Sources: nasdaq.com · Primary article · FireStrike proprietary index